Virulence

metrics 2024

Empowering Researchers with Open Access Discoveries

Introduction

Virulence, a leading academic journal published by Taylor & Francis Inc, is dedicated to advancing the understanding of virulence mechanisms in pathogens across various infectious diseases. Since becoming an Open Access publication in 2018, it has broadened the accessibility of cutting-edge research for a global audience, promoting collaboration and knowledge-sharing among researchers, professionals, and students alike. With a significant impact within its field, the journal boasts impressive 2023 quartile rankings: Q2 in Immunology and Q1 in both Infectious Diseases and Microbiology, alongside notable standings in Parasitology. The current Scopus rankings reinforce its prominence, with high percentiles indicating its influence and relevance in advancing scientific inquiry. Covering a period from 2010 to 2024, Virulence serves as an essential platform for innovative research that not only addresses the critical challenges in understanding pathogen behavior but also contributes towards global health solutions, establishing it as a vital resource in the rapidly evolving fields of immunology, microbiology, and parasitology.

Metrics 2024

SCIMAGO Journal Rank1.31
Journal Impact Factor5.50
Journal Impact Factor (5 years)5.40
H-Index94
Journal IF Without Self5.50
Eigen Factor0.01
Normal Eigen Factor1.40
Influence1.23
Immediacy Index1.30
Cited Half Life6.10
Citing Half Life9.00
JCI0.89
Total Documents1772
WOS Total Citations7200
SCIMAGO Total Citations18202
SCIMAGO SELF Citations551
Scopus Journal Rank1.31
Cites / Document (2 Years)5.54
Cites / Document (3 Years)5.30
Cites / Document (4 Years)5.30

Metrics History

Rank 2024

Scopus

Parasitology in Immunology and Microbiology
Rank #5/79
Percentile 93.67
Quartile Q1
Infectious Diseases in Medicine
Rank #53/344
Percentile 84.59
Quartile Q1
Microbiology (medical) in Medicine
Rank #28/140
Percentile 80.00
Quartile Q1
Microbiology in Immunology and Microbiology
Rank #39/182
Percentile 78.57
Quartile Q1
Immunology in Immunology and Microbiology
Rank #63/236
Percentile 73.31
Quartile Q2

IF (Web Of Science)

IMMUNOLOGY
Rank 39/181
Percentile 78.70
Quartile Q1
INFECTIOUS DISEASES
Rank 13/132
Percentile 90.50
Quartile Q1
MICROBIOLOGY
Rank 24/161
Percentile 85.40
Quartile Q1

JCI (Web Of Science)

IMMUNOLOGY
Rank 53/181
Percentile 70.72
Quartile Q2
INFECTIOUS DISEASES
Rank 38/132
Percentile 71.21
Quartile Q2
MICROBIOLOGY
Rank 56/161
Percentile 65.22
Quartile Q2

Quartile History

Similar Journals

Infectious Diseases

Innovative Research for a Healthier Tomorrow
Publisher: TAYLOR & FRANCIS LTDISSN: 2374-4235Frequency: 12 issues/year

Infectious Diseases, published by TAYLOR & FRANCIS LTD, is a leading academic journal dedicated to advancing research in the field of infectious diseases and microbiology. With an impressive impact factor and categorized in Q1 in multiple areas including Immunology and Microbiology, this journal serves as a critical platform for researchers, practitioners, and students to disseminate their findings and stay abreast of current advancements. The journal is recognized for its rigorous peer-review process and aims to foster innovation and collaboration across disciplines from 2015 to 2024. It boasts a robust Scopus ranking, positioning it favorably among the top-tier of journals in the relevant fields, making it an essential resource for anyone involved in infectious disease research. Access options are available, ensuring that the latest research is accessible to a global audience, thus emphasizing the journal's commitment to promoting knowledge and understanding in the ever-evolving landscape of infectious diseases.

Current Treatment Options in Infectious Diseases

Exploring Cutting-Edge Approaches to Combat Infectious Diseases.
Publisher: SPRINGERNATUREISSN: Frequency: 4 issues/year

Current Treatment Options in Infectious Diseases, published by SpringerNature, is a pivotal peer-reviewed journal dedicated to advancing the field of infectious disease management and therapy. With a focus on the latest treatment modalities, this journal serves as a vital resource for researchers, healthcare professionals, and students striving to improve patient outcomes in infectious diseases. Although it is not an open-access journal, it offers valuable insights through carefully curated articles that emphasize evidence-based practices and innovative approaches in the treatment landscape. By fostering a cross-disciplinary dialogue, Current Treatment Options in Infectious Diseases aims to bridge the gap between research and clinical application, making it an essential platform for staying abreast of developments in this rapidly evolving field.

Indian Journal of Medical Microbiology

Pioneering Research in Medical Microbiology Since 1986
Publisher: ELSEVIERISSN: 0255-0857Frequency: 4 issues/year

Indian Journal of Medical Microbiology, published by Elsevier, is a pivotal peer-reviewed journal dedicated to the field of medical microbiology, providing a vital platform for research and scholarship since its inception in 1986. With an Open Access model established in 2001, it ensures the dissemination of scientific knowledge to a global audience, enhancing accessibility for researchers, professionals, and students alike. The journal's scope spans critical areas including immunology, infectious diseases, and microbiology, with an impressive trajectory marked by converged years of publication allowing for a comprehensive exploration of evolving scientific trends. As of 2023, the journal holds a Q3 ranking in Infectious Diseases and Microbiology (medical) and a Q4 ranking in Immunology and Microbiology categories, reflecting its significant yet growing impact in the field. Researchers seeking to contribute to or stay updated on the latest advancements in medical microbiology will find the Indian Journal of Medical Microbiology a valuable resource, as it consistently bridges the gap between emerging science and clinical application.

COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES

Exploring Host-Pathogen Dynamics for Global Health
Publisher: ELSEVIER SCI LTDISSN: 0147-9571Frequency: 6 issues/year

Comparative Immunology Microbiology and Infectious Diseases, published by Elsevier Science Ltd, is a prominent journal dedicated to advancing the fields of immunology, microbiology, infectious diseases, and veterinary sciences. Established in 1978, this journal has become a vital resource for researchers and professionals alike, with a commendable impact factor that reflects its significance in academia. The journal, available in both print and electronic formats (ISSN: 0147-9571, E-ISSN: 1878-1667), stands out for its commitment to disseminating innovative research findings, particularly through its categorization in Q2 and Q3 quartiles across various related disciplines as of 2023. The journal aims to provide insightful comparative analyses that enhance our understanding of host-pathogen interactions, immune responses, and disease manifestations. With a global readership base, it serves as a platform for collaborative discourse among scientists and professionals, ultimately contributing to the improvement of health outcomes worldwide.

MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS

Showcasing Excellence in Microbial and Molecular Research
Publisher: AMER SOC MICROBIOLOGYISSN: 1092-2172Frequency: 4 issues/year

MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, published by the American Society for Microbiology, is a premier journal dedicated to advancing the fields of microbiology and molecular biology. With an impressive impact factor reflective of its Q1 ranking in categories such as Immunology, Infectious Diseases, and Molecular Biology, this journal consistently showcases high-quality, peer-reviewed articles that contribute to the current understanding of microbial life and molecular mechanisms. Operating since 1997, the journal aims to bridge the gap between microbiological methods and molecular biology applications, making it an essential resource for researchers, professionals, and students alike. Readers can access content through various platforms, ensuring that the latest findings are readily available to the scientific community. With its esteemed reputation, MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS remains a leading voice in the exploration of the life sciences, catering to a broad audience deeply invested in unraveling the complexities of microbial and molecular systems.

New Microbes and New Infections

Exploring the unseen world of microbes and their impact on health.
Publisher: ELSEVIER SCI LTDISSN: Frequency: 6 issues/year

New Microbes and New Infections is an esteemed peer-reviewed journal published by Elsevier Sci Ltd that has been a prominent platform for disseminating groundbreaking research in the fields of Infectious Diseases and Microbiology since its establishment in 2013. With an impressive Open Access model, this journal ensures that vital research findings are readily accessible to researchers, healthcare professionals, and academics worldwide. Positioned in the Q2 category for Infectious Diseases and Q3 for Microbiology in 2023, it reaches a significant global audience, as demonstrated by its high Scopus rankings—#44 out of 344 in Medicine: Infectious Diseases, and #34 out of 182 in Immunology and Microbiology. The journal aims to inspire new ideas and foster collaborations by publishing high-quality research focused on novel microbes and infections, thus playing a crucial role in advancing science and public health in an era where understanding infectious agents is more vital than ever.

Emerging Microbes & Infections

Transforming understanding of infectious challenges.
Publisher: TAYLOR & FRANCIS LTDISSN: Frequency: 1 issue/year

Emerging Microbes & Infections is a premier open access journal, published by Taylor & Francis Ltd since 2012, dedicated to advancing the understanding of microbial infections and their implications in human health. With an impressive Q1 ranking across multiple categories—including Drug Discovery, Epidemiology, Immunology, and Infectious Diseases—this journal is at the forefront of research in the microbiological sciences. Covering a diverse range of topics, it serves as a vital resource for researchers, healthcare professionals, and students alike. The journal's commitment to open access ensures worldwide dissemination of cutting-edge findings, fostering collaboration and innovation in tackling challenges posed by emerging infections. As part of the thriving academic community in the United Kingdom, Emerging Microbes & Infections plays a crucial role in shaping the future of infectious disease research and public health.

Archives of Clinical Infectious Diseases

Elevating Clinical Insights for a Healthier Tomorrow
Publisher: BRIEFLANDISSN: 2345-2641Frequency: 4 issues/year

Archives of Clinical Infectious Diseases is a peer-reviewed journal dedicated to advancing knowledge in the field of infectious diseases, published by BRIEFLAND in Iran. With a broad scope, it covers various aspects of cardiology, critical care, immunology, microbiology, public health, and toxicology, affirming its relevance in today's health landscape. Despite the lack of open access options, the journal maintains a strong reputation, reflected in its Q3 ranking in multiple categories within the 2023 category quartiles. The journal aims to provide a platform for researchers and practitioners to disseminate critical findings that can impact clinical practices and public health policies. Its commitment to rigorous peer review ensures that only high-quality research is published, thereby serving as an essential resource for professionals, students, and public health advocates. For those engaged in the ever-evolving world of infectious diseases, Archives of Clinical Infectious Diseases stands as a vital contribution to the medical literature.

MICROBIAL PATHOGENESIS

Transforming Understanding into Therapeutic Strategies
Publisher: ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTDISSN: 0882-4010Frequency: 12 issues/year

MICROBIAL PATHOGENESIS, published by Academic Press Ltd - Elsevier Science Ltd, is a prominent journal in the fields of Infectious Diseases and Microbiology, with a notable impact factor and classified in the Q2 quartile for both categories as of 2023. Since its inception in 1986, this journal has provided a platform for the dissemination of cutting-edge research that enhances our understanding of microbial infections and their implications in health and disease. The journal is indexed in Scopus, ranking #80 among 344 in Infectious Diseases and #57 among 182 in Microbiology, underscoring its significant contribution to the scientific community. Although it operates under a traditional subscription model, the content is vital for researchers, professionals, and students focused on the dynamics of microbial pathogenesis and the development of innovative therapeutic strategies. The journal's comprehensive scope aims to foster advancements in this critical area of study, bridging the gap between laboratory research and clinical applications.

Microbiology Spectrum

Exploring the vast landscape of microbial science.
Publisher: AMER SOC MICROBIOLOGYISSN: 2165-0497Frequency: 6 issues/year

Microbiology Spectrum is a prominent peer-reviewed journal published by the American Society for Microbiology, dedicated to advancing the field of microbiology through the dissemination of high-quality research. Since its inception in 2013 and continuing until 2024, the journal has established a strong presence in key domains such as microbiology, immunology, cell biology, and ecology, achieving impressive quartile rankings including Q1 in Infectious Diseases and Q1 in Immunology and Microbiology as of 2023. With an emphasis on open access to its scholarly content, Microbiology Spectrum aims to foster collaboration and knowledge sharing among researchers, professionals, and students alike. The journal's scope encompasses a diverse range of topics pertinent to the field, making it an essential resource for anyone involved in microbiological research and its applications. Researchers looking to publish their findings in a respected journal will find Microbiology Spectrum's robust impact factor and Scopus rankings serve as testament to its significance and influence within the academic community.